$ULBI
ULTRALIFE CORP

2024 Q4 Form 10-Q Financial Statement

#000143774924034608 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q4
Revenue $35.69M $44.55M
YoY Change -9.61% 23.38%
Cost Of Revenue $27.01M $33.15M
YoY Change -9.09% 18.27%
Gross Profit $8.682M $11.40M
YoY Change -11.17% 41.1%
Gross Profit Margin 24.32% 25.59%
Selling, General & Admin $6.070M $5.901M
YoY Change 5.2% -4.95%
% of Gross Profit 69.91% 51.75%
Research & Development $2.101M $1.852M
YoY Change 12.41% 11.84%
% of Gross Profit 24.2% 16.24%
Depreciation & Amortization $765.0K $971.0K
YoY Change 0.66% -6.63%
% of Gross Profit 8.81% 8.52%
Operating Expenses $8.171M $7.753M
YoY Change 6.96% -1.41%
Operating Profit $511.0K $3.649M
YoY Change -76.07% 1581.57%
Interest Expense -$173.0K -$566.0K
YoY Change -70.68% 53.8%
% of Operating Profit -33.86% -15.51%
Other Income/Expense, Net -$158.0K -$536.0K
YoY Change -59.07% -10.22%
Pretax Income $353.0K $3.113M
YoY Change -79.82% -919.21%
Income Tax $74.00K $263.0K
% Of Pretax Income 20.96% 8.45%
Net Earnings $258.0K $2.873M
YoY Change -80.6% -1382.59%
Net Earnings / Revenue 0.72% 6.45%
Basic Earnings Per Share $0.02
Diluted Earnings Per Share $0.02 $0.17
COMMON SHARES
Basic Shares Outstanding 16.63M 16.62M 16.34M
Diluted Shares Outstanding 16.87M

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.774M $10.28M
YoY Change -26.37% 79.91%
Cash & Equivalents $6.774M $10.20M
Short-Term Investments
Other Short-Term Assets $7.908M $5.949M
YoY Change 21.66% 38.22%
Inventory $43.99M $42.22M
Prepaid Expenses
Receivables $27.75M $31.76M
Other Receivables $0.00 $0.00
Total Short-Term Assets $86.43M $90.20M
YoY Change -3.49% 14.2%
LONG-TERM ASSETS
Property, Plant & Equipment $20.25M $21.12M
YoY Change -4.35% -2.76%
Goodwill $37.79M $37.57M
YoY Change 1.16% 0.38%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.361M $14.28M
YoY Change 114.3% -0.69%
Total Long-Term Assets $86.01M $88.07M
YoY Change -0.63% -1.53%
TOTAL ASSETS
Total Short-Term Assets $86.43M $90.20M
Total Long-Term Assets $86.01M $88.07M
Total Assets $172.4M $178.3M
YoY Change -2.08% 5.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.68M $11.34M
YoY Change -5.86% -29.48%
Accrued Expenses $11.52M $10.39M
YoY Change 5.72% -4.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.000M $2.000M
YoY Change 0.0% 0.0%
Total Short-Term Liabilities $26.20M $23.73M
YoY Change -0.69% -17.93%
LONG-TERM LIABILITIES
Long-Term Debt $5.888M $23.62M
YoY Change -75.58% 22.34%
Other Long-Term Liabilities $4.093M $3.781M
YoY Change 101.43% 100.37%
Total Long-Term Liabilities $9.981M $27.41M
YoY Change -61.82% 29.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.20M $23.73M
Total Long-Term Liabilities $9.981M $27.41M
Total Liabilities $37.81M $52.94M
YoY Change -30.43% 1.52%
SHAREHOLDERS EQUITY
Retained Earnings -$34.64M -$40.75M
YoY Change -20.61% -15.01%
Common Stock $2.106M $2.078M
YoY Change 1.49% 1.02%
Preferred Stock
YoY Change
Treasury Stock (at cost) $21.49M
YoY Change 0.04%
Treasury Stock Shares
Shareholders Equity $134.5M $125.3M
YoY Change
Total Liabilities & Shareholders Equity $172.4M $178.3M
YoY Change -2.08% 5.85%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q4
OPERATING ACTIVITIES
Net Income $258.0K $2.873M
YoY Change -80.6% -1382.59%
Depreciation, Depletion And Amortization $765.0K $971.0K
YoY Change 0.66% -6.63%
Cash From Operating Activities $4.746M $2.429M
YoY Change -633.26% -5.27%
INVESTING ACTIVITIES
Capital Expenditures $594.0K $1.002M
YoY Change 10.0% 254.06%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$594.0K -$1.002M
YoY Change 10.0% 254.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.077M -300.0K
YoY Change -267.78% -81.0%
NET CHANGE
Cash From Operating Activities 4.746M 2.429M
Cash From Investing Activities -594.0K -1.002M
Cash From Financing Activities -4.077M -300.0K
Net Change In Cash 75.00K 1.127M
YoY Change -92.5% 60.54%
FREE CASH FLOW
Cash From Operating Activities $4.746M $2.429M
Capital Expenditures $594.0K $1.002M
Free Cash Flow $4.152M $1.427M
YoY Change -390.35% -37.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20783607
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16347493
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2078000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
189160000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40754000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
120604000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
114096000 usd
us-gaap Gross Profit
GrossProfit
27798000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17370000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
8491000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
5826000 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
1111000 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
1450000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
426000 usd
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
14513
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
16-1387013
dei City Area Code
CityAreaCode
315
us-gaap Cost Of Revenue
CostOfRevenue
86298000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
8682000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
9774000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3711000 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16626513
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
191582000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3084000 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4436114
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
21492000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.1
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.1
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.1
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.1
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Entity Address Address Line1
EntityAddressAddressLine1
2000 Technology Parkway
dei Entity Address City Or Town
EntityAddressCityOrTown
Newark
CY2023Q4 us-gaap Cash
Cash
10278000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
300000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31761000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
42215000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5949000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
90203000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21117000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
37571000 usd
CY2023Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
15107000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10567000 usd
CY2023Q4 us-gaap Assets
Assets
178276000 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21062627
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
2106000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34636000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3660000 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4436114
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
21492000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
134476000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
125332000 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
153000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
95000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
134629000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
125427000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
172440000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
178276000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
35694000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
39488000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
27012000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
29714000 usd
us-gaap Cost Of Revenue
CostOfRevenue
88889000 usd
us-gaap Gross Profit
GrossProfit
31715000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1869000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5854000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5679000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6070000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5770000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16293000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
8171000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
7639000 usd
us-gaap Operating Expenses
OperatingExpenses
21972000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
511000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2135000 usd
CY2024Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
173000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
200000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1628000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-158000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-386000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-685000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
178000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
353000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1749000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7806000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6004000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
74000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
446000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1630000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1688000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
279000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
1303000 usd
us-gaap Profit Loss
ProfitLoss
6176000 usd
us-gaap Profit Loss
ProfitLoss
4316000 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
21000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-27000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
58000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-8000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
258000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1330000 usd
us-gaap Net Income Loss
NetIncomeLoss
6118000 usd
us-gaap Net Income Loss
NetIncomeLoss
4324000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
811000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-330000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
576000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-426000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1069000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6694000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3898000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16625000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16238000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16530000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16172000
CY2024Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
249000
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
65000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
212000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16303000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16742000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16174000
us-gaap Profit Loss
ProfitLoss
6176000 usd
us-gaap Profit Loss
ProfitLoss
4316000 usd
us-gaap Depreciation
Depreciation
2294000 usd
us-gaap Depreciation
Depreciation
2282000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
684000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
663000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
44000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
48000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
490000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
424000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-1295000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-1245000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4122000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-565000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1553000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5626000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2670000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1972000 usd
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
2708000 usd
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-2448000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13590000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-503000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1326000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1547000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1326000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1547000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6774000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9301000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
119675000 usd
us-gaap Operating Expenses
OperatingExpenses
23224000 usd
dei Document Type
DocumentType
10-Q
dei Entity File Number
EntityFileNumber
0-20852
dei Entity Registrant Name
EntityRegistrantName
ULTRALIFE CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Local Phone Number
LocalPhoneNumber
332-7100
dei Security12b Title
Security12bTitle
Common Stock, $0.10 par value per share
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16626930
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2101000 usd
dei Document Transition Report
DocumentTransitionReport
false
dei Trading Symbol
TradingSymbol
ULBI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0000875657
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2023Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2024Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2024Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2021Q4 us-gaap Debt Instrument Variable Interest Rate Type Extensible Enumeration
DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember
CY2024Q3 us-gaap Cash
Cash
6774000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
301000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27754000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
43994000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7908000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
86430000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20245000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
37792000 usd
CY2024Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
14487000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9125000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4361000 usd
CY2024Q3 us-gaap Assets
Assets
172440000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
12681000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11336000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2000000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2000000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2631000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3115000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8892000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7279000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
26204000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
23730000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5888000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
23624000 usd
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1626000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1714000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4093000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3781000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
37811000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
52849000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
586000 usd
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16874000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
68000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
-0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1960000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1041000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15820000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5791000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-153000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3504000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3588000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10278000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5713000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
116403000 usd
us-gaap Profit Loss
ProfitLoss
4316000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1041000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
421000 usd
ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
3000 usd
us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-426000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
121758000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
125427000 usd
us-gaap Profit Loss
ProfitLoss
6176000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
472000 usd
ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
18000 usd
us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
576000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
134629000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
1303000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
979000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
130000 usd
CY2023Q3 ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
1000 usd
CY2023Q3 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-330000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
121758000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
133345000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
279000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
164000 usd
CY2024Q3 ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
6000 usd
CY2024Q3 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
811000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
134629000 usd
CY2024Q3 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
864854
CY2024Q3 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
5229
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
249082
CY2023Q3 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
677029
CY2023Q3 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
2500
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
65275
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
786854
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
5229
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
212072
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
22165
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
2500
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2441
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6774000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10196000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
82000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6774000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10278000 usd
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
30694000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
29098000 usd
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3108000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3187000 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10192000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9930000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
43994000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
42215000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
88184000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
87601000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
67939000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
66484000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20245000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21117000 usd
CY2024Q3 us-gaap Depreciation
Depreciation
765000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
760000 usd
us-gaap Depreciation
Depreciation
2294000 usd
us-gaap Depreciation
Depreciation
2282000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
37571000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
221000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
37792000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
28446000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13959000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14487000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
28247000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13140000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15107000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
229000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
227000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
684000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
663000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
170000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
131000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
490000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
424000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1250595
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.1
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3460
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.84
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
291841
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.11
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
97360
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8.61
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
864854
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.93
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y29D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1891000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
772369
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
7.01
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y11M4D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1630000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
433028
CY2024Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
7.58
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y8M1D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
696000 usd
CY2024Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
24000 usd
CY2023Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
979000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1960000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1041000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.209 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.281 pure
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
242000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
252000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
772000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
732000 usd
CY2024Q3 us-gaap Variable Lease Cost
VariableLeaseCost
24000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
28000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
76000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
85000 usd
CY2024Q3 us-gaap Lease Cost
LeaseCost
266000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
280000 usd
us-gaap Lease Cost
LeaseCost
848000 usd
us-gaap Lease Cost
LeaseCost
817000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
768000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
762000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1391000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
310000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4194000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3589000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1015000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
894000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3155000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2644000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
4170000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3538000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y10M24D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3M18D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.068 pure
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.045 pure
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
272000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1034000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
958000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
985000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
993000 usd
CY2024Q3 ulbi Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
634000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4876000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
706000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
4170000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
547000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
323000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
911000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
260000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
591000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
98000 usd
CY2024Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
867000 usd
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
485000 usd
CY2024Q3 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
1227000 usd
CY2023Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
1407000 usd
CY2024Q3 us-gaap Revenues
Revenues
35694000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
511000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-158000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
74000 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
21000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
258000 usd
CY2023Q3 us-gaap Revenues
Revenues
39488000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2135000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-386000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
446000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-27000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1330000 usd
us-gaap Revenues
Revenues
120604000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
8491000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-685000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1630000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
58000 usd
us-gaap Net Income Loss
NetIncomeLoss
6118000 usd
us-gaap Revenues
Revenues
114096000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
5826000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
178000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1688000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-8000 usd
us-gaap Net Income Loss
NetIncomeLoss
4324000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
35694000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
39488000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
120604000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
114096000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
35694000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
39488000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
120604000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
114096000 usd

Files In Submission

Name View Source Status
0001437749-24-034608-index-headers.html Edgar Link pending
0001437749-24-034608-index.html Edgar Link pending
0001437749-24-034608.txt Edgar Link pending
0001437749-24-034608-xbrl.zip Edgar Link pending
ex_741997.htm Edgar Link pending
ex_741998.htm Edgar Link pending
ex_741999.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ulbi-20240930.xsd Edgar Link pending
ulbi20240930_10q.htm Edgar Link pending
ulbi-20240930_cal.xml Edgar Link unprocessable
ulbi-20240930_def.xml Edgar Link unprocessable
ulbi-20240930_lab.xml Edgar Link unprocessable
ulbi-20240930_pre.xml Edgar Link unprocessable
ulbi20240930_10q_htm.xml Edgar Link completed